Robert Kristal E.'s most recent trade in BioRestorative Therapies Inc was a trade of 166,492 Stock Option done . Disclosure was reported to the exchange on Feb. 14, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
BioRestorative Therapies Inc | Robert E. Kristal | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 166,492 | 166,492 | - | - | Stock Option | |
BioRestorative Therapies Inc | Robert Kristal E. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 263,158 | 263,158 | - | - | Stock Option | |
BioRestorative Therapies Inc | Robert E. Kristal | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 88,968 | 88,968 | - | - | Stock Option | |
BioRestorative Therapies Inc | Robert E. Kristal | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Nov 2022 | 10,490 | 0 | - | - | Stock Option | |
BioRestorative Therapies Inc | Robert E. Kristal | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2022 | 10,490 | 10,490 | - | - | Stock Option | |
BioRestorative Therapies Inc | Robert E. Kristal | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 3.61 per share. | 15 Jun 2022 | 194 | 7,994 | - | 3.6 | 700 | Common Stock |
BioRestorative Therapies Inc | Robert E. Kristal | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 4.56 per share. | 07 Jun 2022 | 200 | 7,800 | - | 4.6 | 912 | Common Stock |
BioRestorative Therapies Inc | Robert E. Kristal | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 5.71 per share. | 08 Apr 2022 | 7,600 | 7,600 | - | 5.7 | 43,396 | Common Stock |
BioRestorative Therapies Inc | Robert E. Kristal | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2021 | 10,490 | 10,490 | - | - | Stock Option |